Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients

Hepatocellular carcinoma (HCC) is a common lethal disease in Asia and there is no effective chemotherapy. Identification of new effective drugs in the treatment of inoperable HCC is urgently need. This is a phase II clinical study to investigate the efficacy, toxicity and pharmacokinetics of paclita...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 1998-07, Vol.78 (1), p.34-39
Hauptverfasser:	Chao, Y, Chan, W-K, Birkhofer, MJ, Hu, OY-P, Wang, S-S, Huang, Y-S, Liu, M, Whang-Peng, J, Chi, K-H, Lui, W-Y, Lee, S-D
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic agents Antineoplastic Agents, Phytogenic - adverse effects Antineoplastic Agents, Phytogenic - pharmacokinetics Antineoplastic Agents, Phytogenic - therapeutic use Biological and medical sciences Biomedical and Life Sciences Biomedicine Cancer Research Carcinoma, Hepatocellular - drug therapy Carcinoma, Hepatocellular - metabolism Chemotherapy clinical-oncology Drug Resistance Epidemiology Female Humans Liver Neoplasms - drug therapy Liver Neoplasms - metabolism Male Medical sciences Middle Aged Molecular Medicine Oncology Paclitaxel - adverse effects Paclitaxel - pharmacokinetics Paclitaxel - therapeutic use Pharmacology. Drug treatments Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!